David Ledbetter

Chief clinical officer
Dascena

David Ledbetter is chief clinical officer of Dascena, a personalized medicine company.

From this contributor

By David Ledbetter, Scott Myers

23 March 2021

5 min read

There are no autism-specific genes, just brain genes

There is not yet a single example of a gene that, when mutated, increases the likelihood of autism but not of other neurodevelopmental conditions, including intellectual disability.

Spectrum

There are no autism-specific genes, just brain genes

By David Ledbetter, Scott Myers

23 March 2021 | 5 min read

Spectrum

By David Ledbetter

6 May 2013

3 min read

Developmental disorders should be viewed as continuum

Intellectual disability, autism, epilepsy and schizophrenia should be considered part of a spectrum of developmental brain dysfunction, says David Ledbetter.

Spectrum

Developmental disorders should be viewed as continuum

By David Ledbetter

6 May 2013 | 3 min read

Explore more from The Transmitter

Treatments

By Calli McMurray

2 June 2026

5 min read

Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

Treatments